Yonsei Med J.  2002 Jun;43(3):391-394. 10.3349/ymj.2002.43.3.391.

Ceftriaxone Induced Immune Hemolytic Anemia: Detection of Drug-dependent Antibody by Ex-vivo Antigen in Urine

Affiliations
  • 1Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. hyunok1019@yumc.yonsei.ac.kr
  • 2Department of Orthopedics, Yonsei University College of Medicine, Seoul, Korea.

Abstract

There have been a few reported cases of immune hemolytic anemia induced by ceftriaxone. We encountered a patient with immune hemolytic anemia that seemed to be stimulated by a degradation product of ceftriaxone. The patient's direct antiglobulin test was positive only for C3d, and no ceftriaxone-dependent antibodies were detectable in the patient's serum. To demonstrate the presence of the ceftriaxone-induced antibodies, an ex-vivo antigen in urine was obtained from the patient. In addition, we prepared a 1 mg/mL suspension solution of ceftriaxone, and group AB serum as a complement source. Using several combinations of the above reactants, the indirect antiglobulin test was performed. Only the indirect antiglobulin test using the patient's serum with the ex-vivo urine antigen was found to be positive. Other combinations were not reactive. To our knowledge, this is the first reported case in Korea, in which the causative antibody appeared to be stimulated solely by a degradation product of ceftriaxone.

Keyword

Ceftriaxone; drug-dependent antibody; immune hemolytic anemia; ex-vivo antigen

MeSH Terms

Anemia, Hemolytic, Autoimmune/*chemically induced/*diagnosis/immunology/urine
Antigens/urine
Case Report
Ceftriaxone/*adverse effects
Cephalosporins/*adverse effects
Coombs' Test
Human
Male
Middle Age

Cited by  1 articles

A Case of Immune Hemolytic Anemia Induced by Ceftizoxime and Cefobactam (Sulbactam/Cefoperazone)
Eun Jung Baek, Sungsil Lee, Sinyoung Kim, Hyun Kyung Choi, Hyun Ok Kim
Korean J Lab Med. 2009;29(6):578-384.    doi: 10.3343/kjlm.2009.29.6.578.

Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr